Search

Displaying results 6091 - 6100 of 10000 in total
  1. Drug

    Pazufloxacin

    go.drugbank.com/drugs/DB11774
    Investigational

    Pazufloxacin is under investigation in clinical trial NCT02592096 (Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol).

    Categories: Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inhibitors
  2. Drug

    Allicin

    go.drugbank.com/drugs/DB11780
    Investigational

    Allicin has been used in trials studying the treatment of Follicular Lymphoma.

    Categories: Compounds used in a research, industrial, or household setting, P-glycoprotein inhibitors
  3. Drug

    Leukotriene D4

    go.drugbank.com/drugs/DB11858
    Investigational

    Leukotriene D4 has been used in trials studying the diagnostic of Asthma and Allergic Rhinitis.

    Categories: SRS-A
  4. Drug

    Valspodar

    go.drugbank.com/drugs/DB11869
    Investigational

    Valspodar has been used in trials studying the treatment of Cancer, Sarcoma, Leukemia, Lymphoma, and Breast Cancer, among others.

    Categories: P-glycoprotein inhibitors, P-glycoprotein substrates
  5. Drug

    Tetramethrin

    go.drugbank.com/drugs/DB13752
    Experimental

    Categories: P-glycoprotein inhibitors, Compounds used in a research, industrial, or household setting
  6. Drug

    Dexrabeprazole

    go.drugbank.com/drugs/DB13762
    Investigational

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C19 Substrates
  7. Drug

    Monoxerutin

    go.drugbank.com/drugs/DB13764
    Experimental

    Monoxerutin is a flavonol, a type of flavonoid.

  8. Drug

    Prenalterol

    go.drugbank.com/drugs/DB13777
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  9. Drug

    Xamoterol

    go.drugbank.com/drugs/DB13781
    Approved

    Xamoterol is a β1-adrenoceptor partial agonist that has shown to improve systolic and diastolic function in studies with heart failure patients.

  10. Drug

    Reposal

    go.drugbank.com/drugs/DB13805
    Experimental

    Reposal is a barbiturate derivative invented in the 1960s in Denmark that has sedative, hypnotic and anticonvulsant properties. It was used primarily in the treatment of insomnia.